piperonyl butoxide has been researched along with Hypertrophy in 3 studies
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, S | 1 |
Taketa, Y | 1 |
Inoue, K | 2 |
Takahashi, M | 2 |
Matsuo, S | 1 |
Irie, K | 1 |
Watanabe, G | 1 |
Yoshida, M | 2 |
Sakamoto, Y | 1 |
Tamura, K | 1 |
Kodama, Y | 1 |
Butler, WH | 1 |
Gabriel, KL | 1 |
Osimitz, TG | 1 |
Preiss, FJ | 1 |
3 other studies available for piperonyl butoxide and Hypertrophy
Article | Year |
---|---|
Effects of pyperonyl butoxide on the female reproductive tract in rats.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor alpha; Estrous | 2013 |
Dose-dependent difference of nuclear receptors involved in murine liver hypertrophy by piperonyl butoxide.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cyto | 2015 |
Oncogenicity studies of piperonyl butoxide in rats and mice.
Topics: Adenoma, Liver Cell; Administration, Oral; Animals; Body Weight; Carcinogenicity Tests; Carcinogens; | 1998 |